iSolve and the BlockRx Project – 7 Pharma Use Cases for the Blockchain for 2017!
Finally, 2017! For those of us involved in Blockchain Pharma initiatives, 2017 is going to be a very exciting and challenging year! The Pharma industry, which include Providers, Manufacturers, Wholesalers, 3PL and Retailers are working diligently to expand their Blockchain footprint by leveraging additional business units to utilize the Blockchain as a method to provide …
Using ADLT™ to Facilitate Therapeutic Drug Development-Investor Perspective
Investors face multiple challenges in identifying the right portfolio company for their funds. Currently, only about 1/3rd of investments return the 3.5-5x Cash on Cash returns expected of a successful VC firm. On the other side of the coin, companies have a difficult time connecting with the right investors and Investment Associates spend a lot …
Using ADLT™ to Facilitate Therapeutic Drug Development-Tech Transfer Office Perspective
According to the United States Patent Office, the top 250 Universities spent $62 million on R&D and filed over 4,000 patents in 2011. These patents and the subsequent licenses generate revenue that can be reinvested in further research, improving infrastructure, and the student experience. In 2014, the World Intellectual Property Organization stated that 2.7M patents …
The Information Supply Chain: Facilitating Outcome Based Pricing
According to an August 9th, 2016 article by Reuters, Analysis-Future of Drug Pricing: Paying for Benefits not per Pill, it was stated “..shifting the overall industry to a new model (paying for clinical outcomes) requires improvements in data collection and a change in thinking..”. The article later stated that, “Drug companies and healthcare providers will …